X Bioscience Public Company Limited(TH:XBIO)
฿0.040.00 (0.00%)
TH:XBIO
X Bioscience Public Company Limited financials statements
฿0.04
At close:0.00 (0.00%)
X Bioscience Public Company Limited (XBIO) Ratios
X Bioscience Public Company Limited Ratios
TH:XBIO's free cash flow for Q2 2026 was ฿-212.99M. For the 2026 fiscal year, TH:XBIO's free cash flow was decreased by ฿-164.11M and operating cash flow was ฿-48.88M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.93 | 0.25 | 0.17 | 0.12 | 0.22 |
| Quick Ratio | 0.92 | 0.22 | 0.15 | 0.09 | 0.14 |
| Cash Ratio | 0.00 | 0.02 | 0.06 | 0.04 | 0.06 |
| Solvency Ratio | -1.11 | -0.33 | -0.18 | -0.31 | -0.24 |
| Operating Cash Flow Ratio | -0.28 | -0.09 | -0.18 | -0.33 | -0.31 |
| Short-Term Operating Cash Flow Coverage | -0.49 | -0.15 | -0.26 | -0.44 | -0.46 |
| Net Current Asset Value | ฿ -84.39M | ฿ -479.75M | ฿ -485.39M | ฿ -542.43M | ฿ -547.72M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.39 | 0.25 | 0.56 | 0.68 | 0.36 |
| Debt-to-Equity Ratio | 1.11 | 0.69 | 2.27 | 4.61 | 0.70 |
| Debt-to-Capital Ratio | 0.53 | 0.41 | 0.69 | 0.82 | 0.41 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.01 | 0.04 | 0.09 | 0.02 |
| Financial Leverage Ratio | 2.81 | 2.75 | 4.04 | 6.83 | 1.96 |
| Debt Service Coverage Ratio | -1.94 | -0.55 | -0.18 | -0.32 | 0.11 |
| Interest Coverage Ratio | -17.33 | -7.33 | -3.01 | -1.74 | -18.34 |
| Debt to Market Cap | 1.48 | 0.05 | 0.07 | 0.03 | 0.01 |
| Interest Debt Per Share | 0.35 | 0.29 | 0.52 | 0.65 | 0.59 |
| Net Debt to EBITDA | -0.58 | -1.96 | -6.25 | -3.42 | 15.23 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.86% | 43.42% | 48.79% | 49.98% | 46.90% |
| EBIT Margin | -350.78% | -76.31% | -34.87% | -81.25% | -22.09% |
| EBITDA Margin | -319.85% | -55.23% | -19.92% | -38.81% | 7.02% |
| Operating Profit Margin | -350.78% | -78.69% | -38.63% | -28.62% | -64.25% |
| Pretax Profit Margin | -351.80% | -87.05% | -47.68% | -97.66% | -68.39% |
| Net Profit Margin | -361.93% | -81.51% | -47.32% | -96.02% | -67.03% |
| Continuous Operations Profit Margin | -349.29% | -82.09% | -47.32% | -96.02% | -24.22% |
| Net Income Per EBT | 102.88% | 93.63% | 99.24% | 98.32% | 98.00% |
| EBT Per EBIT | 100.29% | 110.63% | 123.44% | 341.24% | 106.45% |
| Return on Assets (ROA) | -76.95% | -18.40% | -19.95% | -47.25% | -20.93% |
| Return on Equity (ROE) | -216.45% | -50.67% | -80.70% | -322.57% | -41.05% |
| Return on Capital Employed (ROCE) | -160.29% | -25.61% | -38.45% | -40.57% | -30.50% |
| Return on Invested Capital (ROIC) | -93.16% | -18.83% | -18.79% | -15.79% | -21.46% |
| Return on Tangible Assets | -112.96% | -34.25% | -42.56% | -117.05% | -62.88% |
| Earnings Yield | -365.47% | -5.45% | -3.55% | -3.08% | -1.17% |
| Efficiency Ratios | |||||
| Receivables Turnover | 9.12 | 6.36 | 10.70 | 19.17 | 39.02 |
| Payables Turnover | 1.99 | 3.87 | 5.66 | 5.83 | 3.08 |
| Inventory Turnover | 34.51 | 15.22 | 23.60 | 13.16 | 6.24 |
| Fixed Asset Turnover | 1.31 | 0.55 | 1.46 | 1.98 | 1.40 |
| Asset Turnover | 0.21 | 0.23 | 0.42 | 0.49 | 0.31 |
| Working Capital Turnover Ratio | -0.74 | -0.94 | -0.82 | -0.91 | -1.96 |
| Cash Conversion Cycle | -132.55 | -12.84 | -14.92 | -15.80 | -50.47 |
| Days of Sales Outstanding | 40.00 | 57.43 | 34.13 | 19.04 | 9.35 |
| Days of Inventory Outstanding | 10.58 | 23.98 | 15.46 | 27.73 | 58.53 |
| Days of Payables Outstanding | 183.13 | 94.26 | 64.51 | 62.57 | 118.35 |
| Operating Cycle | 50.58 | 81.41 | 49.59 | 46.77 | 67.88 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.12 | -0.03 | -0.09 | -0.19 | -0.17 |
| Free Cash Flow Per Share | -0.13 | -0.05 | -0.15 | -0.36 | -0.26 |
| Dividend Paid and CapEx Coverage Ratio | -25.46 | -1.03 | -1.33 | -1.10 | -1.89 |
| Capital Expenditure Coverage Ratio | -25.46 | -1.03 | -1.33 | -1.10 | -1.89 |
| Operating Cash Flow Coverage Ratio | -0.38 | -0.11 | -0.18 | -0.32 | -0.30 |
| Operating Cash Flow to Sales Ratio | -0.71 | -0.12 | -0.24 | -0.44 | -0.34 |
| Free Cash Flow Yield | -74.06% | -1.55% | -3.21% | -2.71% | -0.90% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.27 | -18.58 | -27.88 | -32.22 | -85.15 |
| Price-to-Sales (P/S) Ratio | 0.99 | 14.95 | 13.34 | 31.21 | 57.13 |
| Price-to-Book (P/B) Ratio | 0.59 | 9.30 | 22.75 | 104.85 | 34.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.35 | -64.71 | -31.13 | -36.92 | -110.85 |
| Price-to-Operating Cash Flow Ratio | -1.40 | -127.49 | -54.49 | -70.55 | -169.35 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | -1.58 | 0.48 | -1.56 | 0.00 |
| Enterprise Value Multiple | -0.89 | -29.03 | -73.21 | -83.85 | 828.95 |
| Enterprise Value | 367.08M | 5.12B | 4.55B | 11.21B | 24.00B |
| EV to EBITDA | -0.89 | -29.03 | -73.21 | -83.85 | 828.95 |
| EV to Sales | 2.83 | 16.04 | 14.58 | 32.54 | 58.20 |
| EV to Free Cash Flow | -3.86 | -69.39 | -34.03 | -38.49 | -112.92 |
| EV to Operating Cash Flow | -4.02 | -136.72 | -59.58 | -73.54 | -172.52 |
| Tangible Book Value Per Share | 0.04 | 0.13 | -0.24 | -0.39 | -0.25 |
| Shareholders’ Equity Per Share | 0.29 | 0.38 | 0.21 | 0.13 | 0.83 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.06 | 0.01 | 0.02 | 0.02 |
| Revenue Per Share | 0.17 | 0.24 | 0.36 | 0.42 | 0.51 |
| Net Income Per Share | -0.62 | -0.19 | -0.17 | -0.41 | -0.34 |
| Tax Burden | 1.03 | 0.94 | 0.99 | 0.98 | 0.98 |
| Interest Burden | 1.00 | 1.14 | 1.37 | 1.20 | 3.10 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 3.92 | 1.22 | 0.87 | 0.80 | 1.14 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.20 | 0.13 | 0.52 | 0.26 | 0.50 |
Currency in THB
